318
Participants
Start Date
December 7, 2015
Primary Completion Date
January 24, 2019
Study Completion Date
February 15, 2019
Oral Budesonide Suspension (OBS)
Oral Budesonide Suspension (OBS) 10 milliliter (ml) of 0.2 milligram per milliliter (mg/ml) twice daily up to 16 weeks.
Placebo
Oral dose of 10 ml of placebo matched with the experimental drug.
Mount Sinai Hospital, New York
Long Island Gastrointestinal Research Group LLP, Great Neck
Children's Hospital of Philadelphia, Philadelphia
University of Pennsylvania, Philadelphia
Emeritas Research Group, Lansdowne Town Center
Carilion Clinic, Roanoke
Blue Ridge Medical Research, Lynchburg
Clinical Trials of America-NC, LLC - PPDS, Mount Airy
University of North Carolina at Chapel Hill, Chapel Hill
Clinical Research of Charlotte, Charlotte
Asheville Gastroenterology Associates PA, Asheville
Greenville Hospital System, Greenville
Greenville Hospital System, Greenville
Gastrointestinal Specialists of Georgia, Marietta
Children's Center for Digestive Health Care, Atlanta
Gastroenterology Associates of Central Georgia, LLC, Macon
Accord Clinical Research LLC, Port Orange
Borland Groover Clinic, Jacksonville
Arnold Palmer Hospital For Children, Orlando
Nature Coast Clinical Research LLC, Inverness
Children's Hospital, Birmingham
Vanderbilt University Medical Center, Nashville
Gastro One, Germantown
Great Lakes Gastroenterology, Mentor
Cleveland Clinic, Cleveland
Consultants For Clinical Research Inc, Cincinnati
Cincinnati Children's Hospital Medical Center, Cincinnati
University of Cincinnati, Cincinnati
Gastrointestinal and Liver Diseases Consultants PC, Dayton
Indiana University, Indianapolis
Gastroenterology of Southern Indiana, New Albany
Clinical Research Institute of Michigan, Chesterfield
University of Michigan, Ann Arbor
West Michigan Clinical Research, Wyoming
University of Iowa Hospitals and Clinics, Iowa City
University of Wisconsin, Madison
Minnesota Gastroenterology PA, Plymouth
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Bozeman Health Deaconess Hospital, Bozeman
Center for Children's Digestive Health, Park Ridge
Ann and Robert H Lurie Childrens Hospital of Chicago, Chicago
Northwestern University, Chicago
University of Illinois College of Medicine at Peoria Pediatric Subspecialty Clinic, Peoria
OSF St Francis Medical Center, Peoria
Cotton O'Neil Clinical Research Center, Topeka
Clinical Trials Management LLC, Metairie
Gastroenterology Associates LLC, Baton Rouge
Louisiana Research Center LLC, Shreveport
Clinical Trials of America LA LLC - PPDS, West Monroe
Arkansas Gastroenterology, North Little Rock
Digestive Disease Specialists, Inc., Oklahoma City
Texas Digestive Disease Consultants, Southlake
Baylor College of Medicine, Houston
Houston Endoscopy and Research Center, Houston
Digestive Health Center, Pasadena
San Antonio Military Medical Center, Fort Sam Houston
Rocky Mountain Clinical Research LLC, Wheat Ridge
Colorado Children's Hospital, Aurora
Rocky Mountain Pediatric Gastroenterology, Lone Tree
Asthma and Allergy Associates PC, Colorado Springs
Grand Teton Research Group, PLLC, Idaho Falls
Advanced Research Institute, Ogden
Advanced Research Institute, Sandy City
Primary Children's Hospital, University of Utah, Salt Lake City
Phoenix Childrens Hospital, Phoenix
Del Sol Research Management, Tucson
Adobe Clinical Research LLC, Tucson
GW Research, Inc., Chula Vista
Rady Children's Hospital San Diego, San Diego
Connecticut Clinical Research Foundation, Bristol
Connecticut GI, PC - Research Division, Farmington
Connecticut Children's Medical Center, Hartford
Tufts Medical Center, Boston
Boston Children's Hospital, Boston
Brigham and Womens Hospital, Boston
South Jersey Gastroenterology, Marlton
Lead Sponsor
Shire
INDUSTRY